These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 26041363)

  • 1. Evaluation of work-based screening for early signs of alcohol-related liver disease in hazardous and harmful drinkers: the PrevAIL study.
    Cook PA; Morleo M; Billington D; Sanderson-Shortt K; Jones C; Gabbay M; Sheron N; Bellis MA; Phillips-Howard PA; Gilmore IT
    BMC Public Health; 2015 Jun; 15():532. PubMed ID: 26041363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The alcohol harm paradox: using a national survey to explore how alcohol may disproportionately impact health in deprived individuals.
    Bellis MA; Hughes K; Nicholls J; Sheron N; Gilmore I; Jones L
    BMC Public Health; 2016 Feb; 16():111. PubMed ID: 26888538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feasibility of detection and intervention for alcohol-related liver disease in the community: the Alcohol and Liver Disease Detection study (ALDDeS).
    Sheron N; Moore M; O'Brien W; Harris S; Roderick P
    Br J Gen Pract; 2013 Oct; 63(615):e698-705. PubMed ID: 24152485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acceptability of screening for early detection of liver disease in hazardous/harmful drinkers in primary care.
    Eyles C; Moore M; Sheron N; Roderick P; O'Brien W; Leydon GM
    Br J Gen Pract; 2013 Aug; 63(613):e516-22. PubMed ID: 23972192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevalence of harmful and hazardous alcohol consumption in older U.S. adults: data from the 2005-2008 National Health and Nutrition Examination Survey (NHANES).
    Wilson SR; Knowles SB; Huang Q; Fink A
    J Gen Intern Med; 2014 Feb; 29(2):312-9. PubMed ID: 24101531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease burden and costs from excess alcohol consumption, obesity, and viral hepatitis: fourth report of the Lancet Standing Commission on Liver Disease in the UK.
    Williams R; Alexander G; Armstrong I; Baker A; Bhala N; Camps-Walsh G; Cramp ME; de Lusignan S; Day N; Dhawan A; Dillon J; Drummond C; Dyson J; Foster G; Gilmore I; Hudson M; Kelly D; Langford A; McDougall N; Meier P; Moriarty K; Newsome P; O'Grady J; Pryke R; Rolfe L; Rice P; Rutter H; Sheron N; Taylor A; Thompson J; Thorburn D; Verne J; Wass J; Yeoman A
    Lancet; 2018 Mar; 391(10125):1097-1107. PubMed ID: 29198562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction in Nonabstinent WHO Drinking Risk Levels and Change in Risk for Liver Disease and Positive AUDIT-C Scores: Prospective 3-Year Follow-Up Results in the U.S. General Population.
    Knox J; Wall M; Witkiewitz K; Kranzler HR; Falk D; Litten R; Mann K; O'Malley SS; Scodes J; Anton R; Hasin DS;
    Alcohol Clin Exp Res; 2018 Nov; 42(11):2256-2265. PubMed ID: 30204248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective study of risk drinking: at risk for what?
    Dawson DA; Li TK; Grant BF
    Drug Alcohol Depend; 2008 May; 95(1-2):62-72. PubMed ID: 18243584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Joint use of clinical parameters, biological markers and CAGE questionnaire for the identification of heavy drinkers in a large population-based sample.
    Bataille V; Ruidavets JB; Arveiler D; Amouyel P; Ducimetière P; Perret B; Ferrières J
    Alcohol Alcohol; 2003; 38(2):121-7. PubMed ID: 12634258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cross-sectional study of alcohol consumption and alcoholic liver disease in Beijing: based on 74,998 community residents.
    Wang H; Gao P; Chen W; Yuan Q; Lv M; Bai S; Wu J
    BMC Public Health; 2022 Apr; 22(1):723. PubMed ID: 35410318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The undertreatment of alcohol-related liver diseases among people with alcohol use disorder.
    Scafato E; Caputo F; Patussi V; Balbinot P; Addolorato G; Testino G
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):974-982. PubMed ID: 32017006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Public Health Policies on Alcohol-Associated Liver Disease in Latin America: An Ecological Multinational Study.
    Díaz LA; Idalsoaga F; Fuentes-López E; Márquez-Lomas A; Ramírez CA; Roblero JP; Araujo RC; Higuera-de-la-Tijera F; Toro LG; Pazmiño G; Montes P; Hernandez N; Mendizabal M; Corsi O; Ferreccio C; Lazo M; Brahmania M; Singal AK; Bataller R; Arrese M; Arab JP
    Hepatology; 2021 Nov; 74(5):2478-2490. PubMed ID: 34134172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic liver disease in alcohol-related chronic pancreatitis patients: Does lightning strike twice?
    Soni A; Singh B; Nijhawan S; Mathur A; Gupta G
    Indian J Gastroenterol; 2015 Jul; 34(4):345-6. PubMed ID: 26024741
    [No Abstract]   [Full Text] [Related]  

  • 14. The association between alcohol intake and obesity in a sample of the Irish adult population, a cross-sectional study.
    AlKalbani SR; Murrin C
    BMC Public Health; 2023 Oct; 23(1):2075. PubMed ID: 37875864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are older hazardous and harmful drinkers less likely to participate in health-related behaviors and practices as compared with nonhazardous drinkers?
    Moore AA; Morgenstern H; Harawa NT; Fielding JE; Higa J; Beck JC
    J Am Geriatr Soc; 2001 Apr; 49(4):421-30. PubMed ID: 11347786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. All-cause and liver-related mortality risk factors in excessive drinkers: Analysis of data from the UK biobank.
    Whitfield JB; Seth D; Morgan TR;
    Alcohol Clin Exp Res; 2022 Dec; 46(12):2245-2257. PubMed ID: 36317527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of minimum price per unit of alcohol on patients with liver disease in the UK.
    Sheron N; Chilcott F; Matthews L; Challoner B; Thomas M
    Clin Med (Lond); 2014 Aug; 14(4):396-403. PubMed ID: 25099842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biphasic effect of alcohol intake on the development of fatty liver disease.
    Takahashi H; Ono M; Hyogo H; Tsuji C; Kitajima Y; Ono N; Eguchi T; Fujimoto K; Chayama K; Saibara T; Anzai K; Eguchi Y
    J Gastroenterol; 2015 Nov; 50(11):1114-23. PubMed ID: 25733100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alcohol use in Hefei in relation to alcoholic liver disease: A multivariate logistic regression analysis.
    Huang C; Lv XW; Xu T; Ni MM; Xia JL; Cai SP; Zhou Q; Li X; Yang Y; Zhang L; Yao HW; Meng XM; Wang H; Li J
    Alcohol; 2018 Sep; 71():1-4. PubMed ID: 29864674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alcohol consumption analysis among patients with liver disease in China.
    Xie YD; Zhao CQ; Wang JP; Cheng CS; Zhou JY; Zhang Y; Xia H; Wei L
    Chin Med J (Engl); 2019 Feb; 132(4):420-430. PubMed ID: 30707167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.